特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
919286

世界の注入式ドラッグデリバリー装置市場:2019年~2025年の予測

Global Injectable Drug Delivery Device Market 2019-2025

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
世界の注入式ドラッグデリバリー装置市場:2019年~2025年の予測
出版日: 2019年11月11日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは世界の注入式ドラッグデリバリー装置市場について調査しており、市場機会、成長および阻害要因、装置タイプ・用途・エンドユーザー・競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 レポートの概要

  • 調査方法・ツール
  • 市場分析
    • セグメント別
    • 地域別
    • 利害関係者別

第2章 市場の概要および洞察

  • レポートの範囲
  • アナリストの洞察および現在の市場動向
    • 主な調査結果
    • 提言
    • 結論
  • 規則・規制

第3章 競合情勢

  • 企業シェア分析
  • 主要戦略分析
  • 主要企業分析
    • Cardinal Health, Inc.
    • Gerresheimer AG
    • SCHOTT AG
    • Becton, Dickinson and Co.
    • Wilhelm Haselmeier GmbH & Co. KG

第4章 市場の決定要因

  • 成長要因
  • 阻害要因
  • 市場機会

第5章 市場セグメンテーション

  • 装置タイプ別
    • 従来型
    • 自己注射
  • 用途別
    • CVD
    • 糖尿病
    • 腫瘍
    • 一般の医薬品
    • 予防接種
    • その他(自己免疫疾患)
  • エンドユーザー別
    • 病院
    • 外来センター
    • 診療所
    • ホームケア

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • Becton, Dickinson and Co.
  • Baxter International, Inc.
  • Boehringer Ingelheim GmbH
  • Cardinal Health, Inc.
  • Crossject SA
  • Eli Lilly and Co.
  • Enable Injections, Inc.
  • Gerresheimer AG
  • GlaxoSmithKline PLC
  • Lifelong Meditech Pvt. Ltd.
  • Mylan N.V.
  • Nipro Medical Corp.(ニプロ株式会社)
  • Novartis AG
  • Owen Mumford Ltd.
  • Pfizer Inc.
  • SCHOTT AG
  • SHL Group
  • Stevanato Group
  • テルモ株式会社
  • Wilhelm Haselmeier GmbH & Co. KG
図表

LIST OF TABLES

  • 1. GLOBAL INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL CONVENTIONAL DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL SELF-INJECTABLE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 5. GLOBAL CVD MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL GENERAL MEDICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL VACCINATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 12. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL AMBULATORY CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 16. GLOBAL INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 17. NORTH AMERICAN INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 18. NORTH AMERICAN INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2018-2025 ($ MILLION)
  • 19. NORTH AMERICAN INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 20. NORTH AMERICAN INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 21. EUROPEAN INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 22. EUROPEAN INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2018-2025 ($ MILLION)
  • 23. EUROPEAN INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 24. EUROPEAN INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 25. ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 26. ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2018-2025 ($ MILLION)
  • 27. ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 28. ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 29. REST OF THE WORLD INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2018-2025 ($ MILLION)
  • 30. REST OF THE WORLD INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 31. REST OF THE WORLD INJECTABLE DRUG DELIVERY DEVICE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL INJECTABLE DRUG DELIVERY DEVICE MARKET SHARE BY DEVICE TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL INJECTABLE DRUG DELIVERY DEVICE MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 3. GLOBAL INJECTABLE DRUG DELIVERY DEVICE MARKET SHARE BY END-USER, 2018 VS 2025 (%)
  • 4. GLOBAL INJECTABLE DRUG DELIVERY DEVICE MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 5. US INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. CANADA INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. UK INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. FRANCE INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. GERMANY INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ITALY INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. SPAIN INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. ROE INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. INDIA INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. CHINA INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. JAPAN INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
  • 17. REST OF THE WORLD INJECTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2019949

Title:
Global Injectable Drug Delivery Device
Market Size, Share & Trends Analysis Report by Device Type (Conventional Drug Delivery Devices and Self-Injectable Drug Delivery Devices), by Application (CVD, Diabetes, Oncology, General Medication, Vaccination, and Others), and by End-User (Hospitals, Ambulatory Centers, Clinics, and Homecare) and Forecast 2019-2025.

The global injectable drug delivery device market is growing at a significant CAGR during the forecast period. Increasing cases and their treatment of chronic diseases including CVD, cancer, diabetes, and other major diseases is one of the major factors for the growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), in the US, alone there were 30 million people have diabetes in 2017; whereas, around 84 million people have prediabetes. Growing awareness of vaccination is further augmenting the demand for injectable drug delivery devices across the globe. A major factor limiting the growth of the market is unsafe injection practices by the physicians. Growing adoption of self-injectable drug delivery devices in emerging economies, such as China and India, is expected to act as an opportunity for market growth.

The injectable drug delivery device market is segmented on the basis of device type, application, and end-user. Based on device type, the market is bifurcated into conventional drug delivery devices and self-injectable drug delivery devices. Self-injectable syringes are forecast to rise with a significant growth rate in the market due to the growing adoption of prefilled syringes across the globe. Based on the application, the market is segmented into CVD, diabetes, oncology, general medication, vaccination, and others. Based on end-user, the market is segmented into hospitals, ambulatory centers, clinics, and homecare. Among these end-users, the homecare segment is expected to show a considerable growth rate in the market due to increasing homecare-based injectables, such as insulin patch pumps.

Geographically, the global injectable drug delivery device market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to hold a significant share in the global market due to the availability of patented drugs, awareness toward diseases and vaccination, and increasing adoption of self-injecting drug devices. Asia-Pacific is expected to propel with a significant growth rate in the global market during the forecast period. Rising awareness toward vaccination, increasing health insurance penetration, and rising incidences of chronic diseases are expected to provide lucrative growth to the market in the near future.

The key companies operating in the global injectable drug delivery device market include: Cardinal Health, Inc., Gerresheimer AG, Schott AG, Becton, Dickinson and Co., Wilhelm Haselmeier GmbH & Co. KG, and Pfizer Inc. The market players are significantly contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market. For instance, in January 2019, Sandoz Inc., a subsidiary of Novartis introduced SYMJEPI (epinephrine) 0.3 mg injection in the US market. The injection is for emergency treatment of allergic reactions including anaphylaxis.

Research Methodology

The market study of the global injectable drug delivery device market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for drug manufacturers, injectable device manufacturers, contract manufacturers, government organizations for the overall market and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • 1. Global Injectable Drug Delivery Device Market Research and Analysis by Device Type
  • 2. Global Injectable Drug Delivery Device Market Research and Analysis by Application
  • 3. Global Injectable Drug Delivery Device Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global injectable drug delivery device market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global injectable drug delivery device market.
  • Insights about market determinants which are stimulating the global injectable drug delivery device market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Cardinal Health, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Gerresheimer AG
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. SCHOTT AG
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Becton, Dickinson and Co.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Wilhelm Haselmeier GmbH & Co. KG
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

4.1 Motivators

4.2 Restraints

4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Injectable Drug Delivery Device Market by Device Type
    • 5.1.1. Conventional Drug Delivery Devices
    • 5.1.2. Self-Injectable Drug Delivery Devices
      • 5.1.2.1. Prefilled Syringes
      • 5.1.2.2. Injectable Pens
      • 5.1.2.3. Auto-Injectors
      • 5.1.2.4. Needle-free Injectors
      • 5.1.2.5. Others (Self- Flushing Infusion Bag)
  • 5.2. Global Injectable Drug Delivery Device Market by Application
    • 5.2.1. CVD
    • 5.2.2. Diabetes
    • 5.2.3. Oncology
    • 5.2.4. General Medication
    • 5.2.5. Vaccination
    • 5.2.6. Others (Autoimmune Disorders)
  • 5.3. Global Injectable Drug Delivery Device Market by End-User
    • 5.3.1. Hospitals
    • 5.3.2. Ambulatory Centers
    • 5.3.3. Clinics
    • 5.3.4. Homecare

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Becton, Dickinson and Co.
  • 7.2. Baxter International, Inc.
  • 7.3. Boehringer Ingelheim GmbH
  • 7.4. Cardinal Health, Inc.
  • 7.5. Crossject SA
  • 7.6. Eli Lilly and Co.
  • 7.7. Enable Injections, Inc.
  • 7.8. Gerresheimer AG
  • 7.9. GlaxoSmithKline PLC
  • 7.10. Lifelong Meditech Pvt. Ltd.
  • 7.11. Mylan N.V.
  • 7.12. Nipro Medical Corp.
  • 7.13. Novartis AG
  • 7.14. Owen Mumford Ltd.
  • 7.15. Pfizer Inc.
  • 7.16. SCHOTT AG
  • 7.17. SHL Group
  • 7.18. Stevanato Group
  • 7.19. Terumo Corp.
  • 7.20. Wilhelm Haselmeier GmbH & Co. KG
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.